R.Dresser, “The Reasonable Person Standard for Research Disclosure: A Reasonable Addition to the Common Rule,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 194-202.
2.
Id. at 195.
3.
Id. at 198.
4.
Id. at 198.
5.
Id. at 199.
6.
N.M.P.King, “Key Information in the New Common Rule: Can It Save Research Consent?”Journal of Law, Medicine & Ethics47, no. 2 (2019): 203-212.
7.
Id. at 204.
8.
Id. at 206.
9.
Id. at 208.
10.
H. FernandezLynch, L. E.Wolf, and M.Barnes, “Implementing Regulatory Broad Consent under the Revised Common Rule: Clarifying Key Points and the Need for Evidence,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 213-246.
11.
Id. at 219.
12.
L. M.Lee, “Public Health Data Collection and Implementation of the Revised Common Rule,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 232-237.
13.
Id. at 233-234.
14.
Id. at 235.
15.
Id. at 235.
16.
Id. at 236.
17.
Id. at 237.
18.
J. A.Rolnick, “Learning Health Systems and the Revised Common Rule,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 238-253.
19.
Id. at 240.
20.
Id. at 240.
21.
Id. at 240.
22.
Id. at 240.
23.
Id. at 245.
24.
C. H.Coleman, “Rethinking the Regulatory Triggers for Prospective Ethics Review,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 247-253.
25.
Id. at 251.
26.
Id. at 252.
27.
Z. M.Schrag, “Vexed Again: Social Scientists and the Revision of the Common Rule, 2011-2018,”Journal of Law, Medicine & Ethics47, no. 2 (2019): 254-263.
28.
Id. at 255.
29.
Id. at 258.
30.
Id. at 260.
31.
E. S.Dove, “Requiring a Single IRB for Cooperative Research in the Revised Common Rule: What Lessons Can Be Learned from the UK and Elsewhere?”Journal of Law, Medicine & Ethics47, no. 2 (2019): 264-282.
